aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response PHAT Q1 2026 Earnings Missed EPS Estimates Amid Ongoing Development Efforts RCL Q1 2026 Earnings Strong EPS Beat Drives Market Optimism Dominari Holdings Inc DOMH Q1 2024 Earnings Net Loss Per Share of 035 Amid Ongoing Portfolio Management USFD Q1 2026 Earnings EPS Misses Estimates but Stock Gains Amid Operational Improvements